» Authors » Jeremy Burrows

Jeremy Burrows

Explore the profile of Jeremy Burrows including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 736
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie S, Wang Y, Morton C, Metcalfe R, Dogovski C, Pasaje C, et al.
Nat Commun . 2024 Jan; 15(1):937. PMID: 38297033
Malaria poses an enormous threat to human health. With ever increasing resistance to currently deployed drugs, breakthrough compounds with novel mechanisms of action are urgently needed. Here, we explore pyrimidine-based...
2.
Xie S, Wang Y, Morton C, Metcalfe R, Dogovski C, Pasaje C, et al.
Res Sq . 2023 Aug; PMID: 37546892
Malaria poses an enormous threat to human health. With ever increasing resistance to currently deployed drugs, breakthrough compounds with novel mechanisms of action are urgently needed. Here, we explore pyrimidine-based...
3.
Kumari J, Kumar V, Behl A, Sah R, Kumari G, Garg S, et al.
Biochem Pharmacol . 2022 Oct; 205:115287. PMID: 36209839
The increased resistance of human malaria parasite Plasmodium falciparum (Pf) to currently used drugs necessities the development of novel anti-malarials. Here, we examine the potential of erythritol, a sugar substitute...
4.
Kumari G, Jain R, Sah R, Kalia I, Vashistha M, Singh P, et al.
Biochem Pharmacol . 2022 Jul; 203:115154. PMID: 35798201
The development of resistance to current antimalarial therapies remains a significant source of concern. To address this risk,newdrugswithnoveltargetsin distinct developmental stages ofPlasmodiumparasites are required. In the current study,we have targetedP....
5.
Lim W, Nyuykonge B, Eadie K, Konings M, Smeets J, Fahal A, et al.
PLoS Negl Trop Dis . 2022 Feb; 16(2):e0010159. PMID: 35120131
Eumycetoma is a chronic subcutaneous neglected tropical disease that can be caused by more than 40 different fungal causative agents. The most common causative agents produce black grains and belong...
6.
Yang T, Ottilie S, Istvan E, Godinez-Macias K, Lukens A, Baragana B, et al.
Trends Parasitol . 2021 Mar; 37(6):493-507. PMID: 33648890
The Malaria Drug Accelerator (MalDA) is a consortium of 15 leading scientific laboratories. The aim of MalDA is to improve and accelerate the early antimalarial drug discovery process by identifying...
7.
Bosc N, Felix E, Arcila R, Mendez D, Saunders M, Green D, et al.
J Cheminform . 2021 Feb; 13(1):13. PMID: 33618772
Malaria is a disease affecting hundreds of millions of people across the world, mainly in developing countries and especially in sub-Saharan Africa. It is the cause of hundreds of thousands...
8.
Slater H, Foy B, Kobylinski K, Chaccour C, Watson O, Hellewell J, et al.
Lancet Infect Dis . 2020 Jan; 20(4):498-508. PMID: 31948767
Background: Ivermectin is a potential new vector control tool to reduce malaria transmission. Mosquitoes feeding on a bloodmeal containing ivermectin have a reduced lifespan, meaning they are less likely to...
9.
Anselmi L, Everton A, Shaw R, Suzuki W, Burrows J, Weir R, et al.
Br J Psychiatry . 2019 Aug; 216(6):338-344. PMID: 31391127
Background: Equitable access to mental healthcare is a priority for many countries. The National Health Service in England uses a weighted capitation formula to ensure that the geographical distribution of...
10.
Krieg R, Jortzik E, Goetz A, Blandin S, Wittlin S, Elhabiri M, et al.
Nat Commun . 2019 Jul; 10(1):2997. PMID: 31285434
An amendment to this paper has been published and can be accessed via a link at the top of the paper.